Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Low-Intensity Focused Ultrasound for Cocaine Use Disorder

NCT: NCT05857852 · COMPLETED

NCT IDNCT05857852
StatusCOMPLETED
Start Date2023-03-24
Completion2025-08-31

Brief Summary

This study aims to understand the role of Low-Intensity Focused Ultrasound on craving levels for cocaine as evidenced by diagnostic imaging of the dorsal anterior insula (dAI) and subjective ratings. Data analysis will serve to show if 1) LIFU is safe and effective and to 2) examine the effects of LIFU on dAI BOLD activity and craving in response to cocaine cue-exposure. The study will screen 60 individuals with Cocaine Use Disorder (CUD) to arrive at 30 enrolled subjects, based on a 2:1 screen/randomization ratio.

Frequently Asked Questions

What is Low-Intensity Focused Ultrasound for Cocaine Use Disorder?

Low-Intensity Focused Ultrasound for Cocaine Use Disorder is a clinical trial registered under NCT05857852. Current status: COMPLETED.

What is the status of NCT05857852?

The current status of NCT05857852 (Low-Intensity Focused Ultrasound for Cocaine Use Disorder) is: COMPLETED.

When did Low-Intensity Focused Ultrasound for Cocaine Use Disorder start?

Low-Intensity Focused Ultrasound for Cocaine Use Disorder started on 2023-03-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.